A Bayesian hierarchical analysis of Mediterranean croplands revealed that machine learning algorithm selection shapes soil ...
This pharmaceutical-development technology company continues to demonstrate that its testing platform has real potential.
Pharmaceutical Technology on MSN
Recursion CEO details novel Phase III endpoint for rare disease drug
The AI-driven biotech has secured FDA alignment on a pivotal trial for its FAP therapy, with a study start planned for 2027.
If you picked Recursion Pharmaceuticals for its AI-first pitch and deep pharma ties, the past year has probably felt rough.
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy ...
Recursion Pharmaceuticals had aligned with the FDA on the design of its registrational Phase 3 trial of REC-4881, an ...
Recursion Pharmaceuticals said on November 18, 2026 that it had aligned with the U.S. Food and Drug Administration on a ...
REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy ...
This article presents links to and descriptions of built-in operators and functions for strings and binary types, numeric scalars, aggregations, windows, arrays, maps, dates and timestamps, casting, ...
The aim of the programme is to offer a deep and up-to-date education in data science, machine learning and artificial intelligence that prepares graduates with key knowledge, skills and competencies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results